Enanta Pharmaceuticals (ENTA) Earnings Analysis
Enanta Pharmaceuticals (ENTA) next reports earnings on 2026-08-10, consensus EPS -0.50951 USD. Last quarter (2026-05-11) it beat with EPS -0.45 USD vs -0.46 USD est (+2.2%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E -4.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ENTA next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.50951 USD |
| Revenue estimate | 0.02B |
ENTA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.45 USD | -0.46 USD | +2.2% | Beat |
| 2026-02-09 | -0.42 USD | -0.54 USD | +22.2% | Beat |
| 2025-11-17 | -0.87 USD | -1.13 USD | +23% | Beat |
| 2025-08-11 | -0.85 USD | -1.25 USD | +32% | Beat |
| 2025-05-12 | -1.06 USD | -1.04 USD | -1.9% | Miss |
| 2025-02-10 | -1.05 USD | -1.16 USD | +9.5% | Beat |
| 2024-11-25 | -1.36 USD | -1.16 USD | -17.2% | Miss |
| 2024-08-05 | -1.07 USD | -1.49 USD | +28.2% | Beat |
Beat rate: 6/8 (75%) over reported quarters with consensus data.
ENTA valuation and analyst view
| Trailing P/E | -4.77 |
|---|---|
| Trailing EPS | -2.89916 USD |
| Price / book | 2.39 |
| Dividend yield | 0.00% |
| Market cap | 0.31B |
| Analyst consensus | Buy (14 buy / 3 hold / 2 sell) |
| Avg price target | 20 USD |
Related research pages
Frequently asked questions
When is Enanta Pharmaceuticals (ENTA)'s next earnings date?
Enanta Pharmaceuticals is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.50951 USD and revenue estimate of 0.02B.
Did ENTA beat earnings last quarter?
In its 2026-05-11 report, ENTA posted EPS of -0.45 USD versus a -0.46 USD estimate — a beat of 2.2%.
What is ENTA's earnings track record?
Over the last 8 reported quarters with consensus data, ENTA beat estimates 6 times (75%).
What is ENTA's current P/E ratio and EPS?
ENTA trades at a trailing P/E of -4.77 on trailing EPS of -2.899158091674462 USD.
What do analysts rate ENTA?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 14 buy, 3 hold, 2 sell, 0 strong sell). Average 12-month price target: 20 USD.